
    
      The study was conducted as an open-label, randomized, 2-way crossover study to compare the
      single-dose relative bioavailability of Ranbaxy and GlaxoSmithKline (AugmentinÂ® 400 mg)
      amoxicillin (as the trihydrate)/57 mg clavulanic acid (as the potassium salt) chewable
      tablet, following administration of 2 tablet dose under fasting conditions A total of 40
      subjects (22 males and 18 females) were included in this study, of which 39 (21 males and 18
      females) finished the study according to the protocol.
    
  